Log In
Print
BCIQ
Print
Print this Print this
 

SG1002

  Manage Alerts
Collapse Summary General Information
Company Sulfagenix Inc.
DescriptionHydrogen sulfide prodrug
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHeart failure
Indication DetailsTreat heart failure
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today